Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective

Pablo Ryan1,2,3,4, Jorge Valencia5,1,2, Guillermo Cuevas2

  • 1Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.

Summary

Hepatitis C virus (HCV) infection rates significantly decreased among people who use drugs (PWUD) in Madrid from 2017-2023. This decline, especially notable in people who inject drugs (PWID), indicates successful public health interventions.